Dr. Reddy

Dr. Reddy’s Laboratories Ltd. announced its unaudited financial results for the year ended March 31, 2009 under International Financial Reporting Standards (IFRS). Its FY09 contains following key points:

• Overall revenues at Rs. 69.4 billion ($1.4 billion) in FY09 as against Rs. 50.0 billion ($983 million) in FY08, representing a growth of 39%.

  
  

• The growth was driven by the successful launch of the authorized generic version of GlaxoSmithKline’s Imitrex

  
  
  post_id:
  uld_count:

  Cookie not set

  Like

  Dislike
  
  
  Like

  Value 1: 0

  Value 2: 10

  Follow and connect with us on

  • 

  18-05-2009

  By eHealth Network